IV COURSE ON UPDATES IN THE DIAGNOSIS AND TREATMENT OF THYMIC TUMORS

IV COURSE ON UPDATES IN THE DIAGNOSIS AND TREATMENT OF THYMIC TUMORS


 

Thymic tumors are rare, and the most common type is thymoma, which grows slowly but is malignant in nature. Their prognosis depends on the degree of invasion and the possibility of complete resection. The scarcity of cases means that clinical experience is limited and scattered, and the available literature is mainly based on retrospective series and single-center data, making it difficult to compare results due to a lack of unified classifications.

At the national level, the Thoracic Surgery Service and the Neuromuscular Pathology Unit, led by Dr. Isabel Illa, have been a reference in the treatment of these tumors and the associated paraneoplastic syndromes, creating the country’s first multidisciplinary thymic tumor committee. As a result of this experience, the Update Course on the Diagnosis and Treatment of Thymic Tumors has been organized, with its 4th edition taking place on October 16 and 17, aimed at all professionals involved in their multidisciplinary care.



CONFERENCE PROGRAM

 

COURSE DIRECTOR
Dr. Juan Carlos Trujillo
Joint Thoracic Surgery. Hospital de la Santa
Creu i Sant Pau/Hospital del Mar

ORGANIZING COMITEE
Dr. Josep Belda
Dr. Elisabeth Martínez
Dr. Alejandra Libreros
Dr. Georgina Planas
Dr. Jorge Hernández
Dr. Stephania Chavarria
Dr. Georgina Ros
Dr. Leandro Grando
Dr. Albert Rodriguez
Dr. Rafael Aguiló
Joint Thoracic Surgery Service Hospital de la
Santa Creu i Sant Pau/Hospital del Mar

OBJECTIVE
To update theoretical and practical knowledge
on the diagnosis and treatment of
thymic tumors, both with and without associated
Myasthenia Gravis (MG).

COURSE VENUES
• October 16, 2025 – Sessions streamed
from Sala Pau Gil, Modernist Complex, Hospital
de la Santa Creu i Sant Pau
• October 17, 2025 – Online streaming via
the course website and in-person attendance
at the 4th floor of Hospital de la Santa Creu i
Sant Pau

 

Last Update: 26/09/2025

Asset Publisher

null LHospital de Sant Pau de Barcelona implanta per primera vegada a Espanya un nou dispositiu transcateter a pacients amb insuficiencia mitral severa que millora el seu pronostic evolucio i qualitat de vida

Asset Publisher
12/10/2020
L'Hospital de Sant Pau de Barcelona, implanta per primera vegada a Espanya un nou dispositiu transcatéter a pacients amb insuficiència mitral severa que millora el seu pronòstic, evolució i qualitat de vida


Sant Pau, hospital pioner a Espanya en la introducció en la pràctica clínica dels dispositius transcatéter i centre amb més experiència en aquest tipus d'intervencions, ha implantat un nou dispositiu (Edwards PASCAL ™ transcatheter valve repair system) amb èxit a pacients amb insuficiència mitral

Vídeo: Dispositiu transcatèter

Contacte Cirurgia Toracica

Ubicació i contacte
Ubicació

Secretaria de Pneumologia i Cirurgia Toràcica

Despatxos: 4ª planta mòdul 2

Sala d’hospitalització: sala C2

Consultes externes: planta 3ª, mòdul 5.

Contacte

Servei de Cirurgia Toràcica

Telèfon: 93 556 57 44